Summary
This study employed conditional knockout mice and human cell line models to establish that ROR1 is essential for lung adenocarcinoma development and progression. Ror1 ablation significantly retarded tumour growth and improved survival, whilst mechanistic analysis revealed that ROR1 functions as a novel positive regulator of HIF-1α, both under baseline conditions and in response to hypoxic stress. The findings suggest ROR1 represents a promising therapeutic target for solid tumours characterised by hypoxic microenvironments.
UK applicability
As a laboratory study using transgenic mouse models and human cell lines, the findings are not directly applicable to UK farming or food systems. However, the mechanistic insights into HIF-1α regulation may inform future cancer research and therapeutic development in UK clinical and research settings.
Key measures
Tumour development rate, tumour progression, survival time, malignant characteristics, HIF-1α protein expression under normoxia and hypoxia, hypoxia-induced gene set expression (HALLMARK_HYPOXIA)
Outcomes reported
The study evaluated tumour development, progression, malignant characteristics and survival outcomes in genetically engineered mice with Ror1 ablation. Additionally, the research measured HIF-1α expression levels under normoxic and hypoxic conditions in human lung adenocarcinoma cell lines.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.